Evidence map›Paper›PMID 38993535›Full record

ArticleBladder cancer (Amsterdam, Netherlands)2024

Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer.

David J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, David J DeGraff, Scott E Delacroix, Jason A Efstathiou, Jared Foster, Susan Groshen, Edward E Kadel, Francesca Khani and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bladder cancer (Amsterdam, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

David J McConkeyJohns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA.
Brian C BaumannDepartment of Radiation Oncology, Springfield Clinic, Springfield, IL, USA.
Stephanie Cooper GreenbergPatient Advocate, Baltimore, MD, USA.
David J DeGraffDepartment of Pathology and Laboratory Medicine, Pennsylvania State University, Hershey, PA, USA.
Scott E DelacroixDepartment of Urology, Louisiana State University Health Science Center, New Orleans, New Orleans, LA, USA.
Jason A EfstathiouDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Jared FosterDivision of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
Susan GroshenDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Edward E KadelUS Medical Affairs and Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
Francesca KhaniDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
William Y KimLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Seth P LernerDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Trevor LevinConvergent Genomics, San Francisco, CA, USA.
Joseph C LiaoDepartment of Urology, Stanford University, Stanford, CA, USA.
Matthew I MilowskyLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Joshua J MeeksDepartment of Urology, Feinberg School of Medicine, Chicago, IL, USA.
David T MiyamotoDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kent W MouwDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Eugene J PietzakUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
David B SolitHuman Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Debasish SundiDepartment of Urology, Ohio State University Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, Columbus, OH, USA.
Abdul Tawab-AmiriCoordinating Center for Clinical Trials, National Cancer Institute, NIH, Bethesda, MD, USA.
Pamela J WestEmmes Company, Rockville, MD, USA.
Sara E WobkerUniversity of North Carolina at Chapel Hill, Departments of Pathology and Laboratory Medicine and Urology, Chapel Hill, NC, USA.
Alexander W WyattVancouver Prostate Centre, Department of Urologic Sciences,University of British Columbia, Vancouver, BC, Canada.
Andrea B ApoloGenitourinary Malignancies Branch, National Cancer Institute, Center for Cancer Research, Bethesda, MD, USA.
Peter C BlackVancouver Prostate Centre, Department of Urologic Sciences,University of British Columbia, Vancouver, BC, Canada.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38993535
PMCPMC11181871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.